- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01282671
Effects of Deep Breathing Exercises Two Months After Cardiac Surgery
Hypothesis: Deep breathing exercises performed during the first two months after cardiac surgery, will improve pulmonary function and patient-perceived quality of recovery.
Specific aim: To evaluate the effectiveness of breathing exercises performed with a mechanical device for positive expiratory pressure during the first two months after cardiac surgery compared to a control group performing no breathing exercises.
Design: A prospective, randomized, controlled two-center study.
Study Overview
Detailed Description
Contribution: The study will be taken place at two University hospitals in Sweden.
Uppsala university hospital (PhD, Registered physical therapist (RPT)) Margareta Emtner and RPT Charlotte Urell) and Örebro university hospital; (Elisabeth Westerdahl and RPT Marcus Jonsson).
Time planning: Application to the Research Ethics Committee april 2007. Data collection 2007-2011. Statistical analysis and manuscript writing 2011.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Uppsala, Sweden, 751 85
- Uppsala University
-
Örebro, Sweden, 701 85
- Orebro University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A sample of 360 adults (>18 years) patients undergoing cardiac surgery at the two University hospitals are invited to participate in the study.
- Type of cardiac surgery included will be Coronary artery bypass graft surgery (CABG) with saphenous vein grafts and/or internal mammary artery graft, valve surgery or combinations of CABG and valve surgery.
Exclusion Criteria:
- Patients who have an emergency operation, previous cardiac or lung surgery, renal dysfunction requiring dialysis or are unable to communicate in Swedish will not be included.
- Patients who requires more than 24 hours respirator treatment, reintubation, reoperation, sternum instability/infection or develop a neurological, mental or haemodynamic complication that affects the patients' ability to collaborate, will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Breathing exercises
On the fourth postoperative day the patients are randomly assigned to a Treatment group continuing to perform deep breathing exercises for 2 months postoperatively and to a Control group who will perform no breathing exercises after the third postoperative day.
Patient management is otherwise similar in the groups.
The patients in the Deep breathing group will be instructed to perform breathing exercises (3 x 10 deep breaths) 5 times a day (document compliance) during the two postoperative months.
|
On the fourth postoperative day the patients are randomly assigned to a Treatment group continuing to perform deep breathing exercises for 2 months postoperatively and to a Control group who will perform no breathing exercises after the third postoperative day.
Patient management is otherwise similar in the groups.
The patients in the Deep breathing group will be instructed to perform breathing exercises (3 x 10 deep breaths) 5 times a day (document compliance) during the two postoperative months.
A Positive expiratory pressure (PEP) device PEP ventil, System 22 (Rium Medical, Täby, Sweden) is used to create an expiratory resistance of +10 cm H2O.
Other Names:
|
No Intervention: Control group
No breathing exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lung function measured as Forced expiratory volume in 1 second (FEV1)
Time Frame: Two months after surgery
|
Spirometry is performed preoperatively and 2 months after surgery at the Departments of Clinical Physiology.
A Jaeger MasterScreen Pulmonary functiontest (PFT)/Bodybox will be used at the University hospitals in Uppsala and Örebro.
The medical laboratory technologists are blinded to the patient's treatment allocation.
Static and dynamic lung volumes will be measured.
|
Two months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative quality of recovery
Time Frame: Two months postoperatively
|
Physical activity, postoperative pain, day of discharge, signs of pneumonia or pulmonary comlications will be noted.
Patient-perceived quality of recovery will be assessed using a translated version of a recently validated quality of recovery score (QoR-40) designed to measure the patient's health status after surgery and anaesthesia.
The SF (short form) -36 (first version) will be used for assessment of quality of life aspects.
|
Two months postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elisabeth Westerdahl, PhD, RPT, Region Örebro County
Publications and helpful links
General Publications
- Westerdahl E, Urell C, Jonsson M, Bryngelsson IL, Hedenstrom H, Emtner M. Deep breathing exercises performed 2 months following cardiac surgery: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2014 Jan-Feb;34(1):34-42. doi: 10.1097/HCR.0000000000000020.
- Jonsson M, Urell C, Emtner M, Westerdahl E. Self-reported physical activity and lung function two months after cardiac surgery--a prospective cohort study. J Cardiothorac Surg. 2014 Mar 28;9:59. doi: 10.1186/1749-8090-9-59.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Multic-PEP 2007-160
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CABG
-
Johns Hopkins UniversityTerminated
-
University of VirginiaUnknown
-
Sawanpracharak hospitalNot yet recruiting
-
Konkuk University Medical CenterUnknown
-
University GhentFund for Scientific Research, Flanders, BelgiumCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Unknown
-
Hospital de Clinicas de Porto AlegreCompletedComplication of CABGBrazil
-
Assiut UniversityNot yet recruitingCABG | CAD | LIMA
-
Kerckhoff KlinikCompletedCABG Graft IntegrityGermany
-
Tabriz UniversityUnknownCABG-Induced Oxidative StressIran, Islamic Republic of
Clinical Trials on Breathing exercises
-
Derya AzimCompletedStroke | Physiotherapy and RehabilitationTurkey
-
Riphah International UniversityCompleted
-
Hasan Kalyoncu UniversityCompletedChronic Low-back PainTurkey
-
Federal University of BahiaCompletedParkinson Disease | DysphagiaBrazil
-
Foundation University IslamabadRecruiting
-
Naestved HospitalRecruiting
-
Golden Jubilee National HospitalCompletedCoronary Artery Disease | Lung Cancer | Lung TumorUnited Kingdom
-
Riphah International UniversityCompleted
-
Riphah International UniversityRecruiting
-
Mansoura UniversityCompleted